|
Real-time Estimate
Tradegate
02:35:05 22/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 58.65 EUR | -0.34% |
|
+1.90% | -7.17% |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 345.2Cr | |||||
| 1,03800Cr | |||||
| 65TCr | - | ||||
| 47TCr | |||||
| 36TCr | |||||
| 27TCr |
Select your edition
All financial news and data tailored to specific country editions
